Inhaled Nitric Oxide Delivery Systems Market (By Type Pediatrics, Adult; By Application: Hypoxic Respiratory Failure (HRF), Acute Hypoxemic Respiratory Failure (AHRF); By Product: Disposables, System; By End-use: Hospitals, Ambulatory Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global inhaled nitric oxide delivery systems market size is expected to be worth around US$ 530.2 million by 2030, according to a new report by Vision Research Reports.

The global inhaled nitric oxide delivery systems market size was valued at US$ 260.5 million in 2020 and is anticipated to grow at a CAGR of 7.9% during forecast period 2021 to 2030.

Report Coverage

Report Scope Details
Market Size USD 530.2 million by 2030
Growth Rate CAGR of 7.9% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, application, product, end user
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Mallinckrodt Pharmaceuticals; Getinge; Vero Biotech; LINDE; Beyond Air; SLE; NU MED; Bellerophon Therapeutics; Air Liquide Healthcare; Circassia Pharmaceuticals

Growth Factors

 A rise in the cases of respiratory failure among neonates, increased pollution levels leading to lung diseases in adults, need for quick treatment response, and reduced complications are the factors driving the adoption of inhaled nitric oxide therapy. The presence of several small-scale manufacturers and research initiatives undertaken by major players to prove treatment efficacy against the SARS-CoV-2 virus further enhances market growth.

Safe and effective treatment regimen, a rapid offset of action, reduced toxicity, high concentration of drug at the target organ, avoidance of systemic adverse reaction, and reduced dose of medication are some of the advantages of INO over other medications

By Type Analysis

The pediatric segment accounted for the largest revenue share of 77.6% in 2020. Inhaled nitric oxide is proved to be the most effective in treating neonatal diseases like Hypoxic Respiratory Failure (HRF). 

low cost of raw materials, abundant resource availability, and a large consumer base, are also anticipated to boost segment growth. INO delivery devices are priced at USD 1400-1700, which makes it difficult for low-tier end-user settings to adopt such equipment as they focus on minimizing the bills. 

By End-user Analysis

The hospitals segment captured the highest revenue share of 87.2% in 2020 owing to the ease of delivery, ability to liquidate for establishing INO delivery device and monitor system, a large number of staff to track device operations, and presence of emergency department.

Mortality rates due to ARFare around 30% in the world. Hence, it is essential to provide these patients with life support and critical care, such as that in hospital ICUs. A rise in the number of hospital admissions is leading to the growth of this segment

By Regional Analysis

North America is expected to be the fastest-growing regional market registering a CAGR of 7.84% during the forecast period. This growth can mainly be attributed to the increasing incidences of neonatal mortality due to the rising cases of HRF.

APAC held the largest revenue share in 2020 and will continue the trend during the forecast period due to the growing pediatric population, a rise in the number of patients suffering from respiratory failure, and the presence of local manufacturers of nitric oxide disposables&systems.

Key Players

  • Mallinckrodt Pharmaceuticals

  • Getinge

  • Vero Biotech

  • LINDE

  • Beyond Air

  • SLE

  • NU MED

  • Bellerophon Therapeutics

  • Air Liquide Healthcare

  • Circassia Pharmaceuticals 

Market Segmentation

  • By Type

    • Pediatrics

    • Adult

  • By Application

    • Hypoxic Respiratory Failure (HRF)

    • Acute Hypoxemic Respiratory Failure (AHRF)

    • Others

  • By Product

    • Disposables

    • System

  • By End-user

    • Hospitals

    • Ambulatory Centers

    • Clinics

  • Regional

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Norway

      • Sweden

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Thailand

      • South Korea

      • Australia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Turkey

The Inhaled Nitric Oxide Delivery Systems market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Inhaled Nitric Oxide Delivery Systems market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Inhaled Nitric Oxide Delivery Systems market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inhaled Nitric Oxide Delivery Systems market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Inhaled Nitric Oxide Delivery Systems market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Inhaled Nitric Oxide Delivery Systems capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Inhaled Nitric Oxide Delivery Systems by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Inhaled Nitric Oxide Delivery Systems market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Inhaled Nitric Oxide Delivery Systems market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Inhaled Nitric Oxide Delivery Systems market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Inhaled Nitric Oxide Delivery Systems industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Inhaled Nitric Oxide Delivery Systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Inhaled Nitric Oxide Delivery Systems market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Inhaled Nitric Oxide Delivery Systems market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Inhaled Nitric Oxide Delivery Systems market. These factors have benefited the growth of the global market for Inhaled Nitric Oxide Delivery Systems. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Inhaled Nitric Oxide Delivery Systems. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Inhaled Nitric Oxide Delivery Systems are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Product Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Inhaled Nitric Oxide Delivery Systems Market, By Type

7.1.  Inhaled Nitric Oxide Delivery Systems Market, by Type, 2021-2030

7.1.1.    Pediatrics

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Adult

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Inhaled Nitric Oxide Delivery Systems Market, By Application

8.1.  Inhaled Nitric Oxide Delivery Systems Market, by Application, 2021-2030

8.1.1.    Hypoxic Respiratory Failure (HRF)

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Acute Hypoxemic Respiratory Failure (AHRF)

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Inhaled Nitric Oxide Delivery Systems Market, By Product

9.1.  Inhaled Nitric Oxide Delivery Systems Market, by Product, 2021-2030

9.1.1.    Disposables

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    System

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Inhaled Nitric Oxide Delivery Systems Market, By End-user

10.1.        Inhaled Nitric Oxide Delivery Systems Market, by End-user, 2021-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Ambulatory Centers

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Clinics

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Inhaled Nitric Oxide Delivery Systems Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Application (2017-2030)

11.1.3.  Market Revenue and Forecast, by Product (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Application (2017-2030)

11.2.3.  Market Revenue and Forecast, by Product (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Application (2017-2030)

11.3.3.  Market Revenue and Forecast, by Product (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Application (2017-2030)

11.4.3.  Market Revenue and Forecast, by Product (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Application (2017-2030)

11.5.3.  Market Revenue and Forecast, by Product (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12.  Company Profiles

12.1.              Mallinckrodt Pharmaceuticals

12.1.1.  Company Overview

12.1.2.  Type Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Getinge

12.2.1.  Company Overview

12.2.2.  Type Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Vero Biotech

12.3.1.  Company Overview

12.3.2.  Type Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              LINDE

12.4.1.  Company Overview

12.4.2.  Type Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Beyond Air

12.5.1.  Company Overview

12.5.2.  Type Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              SLE

12.6.1.  Company Overview

12.6.2.  Type Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              NU MED

12.7.1.  Company Overview

12.7.2.  Type Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Bellerophon Therapeutics

12.8.1.  Company Overview

12.8.2.  Type Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Air Liquide Healthcare

12.9.1.  Company Overview

12.9.2.  Type Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Circassia Pharmaceuticals

12.10.1.               Company Overview

12.10.2.               Type Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers